What is Nurix Therapeutics, Inc.'s PP&E (net)?

Nurix Therapeutics, Inc. (NRIX) reported PP&E (net) of $21.7M in Q4 2025.

How has Nurix Therapeutics, Inc.'s PP&E (net) changed year-over-year?

Nurix Therapeutics, Inc.'s PP&E (net) increased by 17.6% year-over-year, from $18.45M to $21.7M.

What is the long-term trend for Nurix Therapeutics, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s PP&E (net) has grown at a 27.5% compound annual growth rate (CAGR), from $6.67M to $22.49M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Nurix Therapeutics, Inc. NRIX PP&E (Net)

PP&E (Net) at other companies

Kymera TherapeuticsKYMR

$41.62M-15.4%

Monte Rosa Therapeutics, Inc.GLUE

$28.41M-3.2%

Stoke Therapeutics, Inc.STOK

$3.4M-6.0%

Viridian Therapeutics, Inc.VRDN

$1.13M-2.8%

Nuvation BioNUVB

$535K-4.8%

Ultragenyx PharmaceuticalRARE

$239M-8.4%

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s PP&E (net)?: Nurix Therapeutics, Inc. (NRIX) reported PP&E (net) of $21.7M in Q4 2025.
How has Nurix Therapeutics, Inc.'s PP&E (net) changed year-over-year?: Nurix Therapeutics, Inc.'s PP&E (net) increased by 17.6% year-over-year, from $18.45M to $21.7M.
What is the long-term trend for Nurix Therapeutics, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s PP&E (net) has grown at a 27.5% compound annual growth rate (CAGR), from $6.67M to $22.49M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.